Hydroxyurea Alternatives Compared
Hydroxyurea | Fluocinonide topical | Cosentyx |
|
---|
Hydroxyurea | Fluocinonide topical | Cosentyx (secukinumab) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Chronic Myelogenous Leukemia, Anemia - Sickle Cell, Solid Tumors. May also be prescribed off label for Glioblastoma Multiforme, Cervical Cancer, Plaque Psoriasis, Polycythemia Vera... View more |
Prescription only
Prescribed for Eczema, Atopic Dermatitis, Dermatitis, Lichen Planopilaris, Psoriasis. May also be prescribed off label for Granuloma Annulare, Lichen Planus. |
Prescription only
Cosentyx may be used to treat plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and some other conditions. After an initial loading dose, Cosentyx needs to be injected subcutaneously... View more |
Related suggestions |
|||||||||||||||||||||||
More about Hydroxyurea | More about Fluocinonide topical | More about Cosentyx (secukinumab) | ||||||||||||||||||||||||
Generic Status | ||||||||||||||||||||||||||
No lower-cost generic available |
||||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Hydroxyurea has an average rating of 6.7 out of 10 from a total of 40 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 26% reported a negative effect. |
Fluocinonide topical has an average rating of 8.2 out of 10 from a total of 53 ratings on Drugs.com. 78% of reviewers reported a positive effect, while 16% reported a negative effect. |
Cosentyx has an average rating of 6.1 out of 10 from a total of 232 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 34% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: hydroxyurea side effects in more detail. |
See also: fluocinonide topical side effects in more detail. |
Common side effects include:
See also: Cosentyx side effects in more detail. |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all hydroxyurea prices |
View all fluocinonide topical prices |
View all Cosentyx prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Droxia, Hydrea, Siklos | Dermacin, Fluex, Fluocinonide-E, Vanos |
N/A |
||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
4 hours |
N/A |
744 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 255 drugs are known to interact with hydroxyurea:
|
A total of 47 drugs are known to interact with fluocinonide topical:
|
A total of 210 drugs are known to interact with Cosentyx:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
December 07, 1967 |
June 30, 1971 |
January 21, 2015 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.